Jake Nunn
InvestorVenture Partner at SR One Capital Management
Menlo Park, California
Writes $50K β $50M checks Β· typically $25M
About
Jake Nunn is a Partner at SR One focused on later-stage private and public biotech investments, with over 25 years in the life sciences industry as an investor, board director, research analyst and investment banker. He previously spent 2006 to 2019 at New Enterprise Associates, where he established the firm's public healthcare investing practice, and earlier worked at MPM Capital, Franklin Templeton Investments and Alex. Brown & Sons. He holds an MBA from Stanford Graduate School of Business, a BA in Economics from Dartmouth College, and the CFA designation.
Invests in
Biotech
Experience
- SR One Capital ManagementPartnercurrent2024 β presentSan Francisco Bay Area
- SR One Capital ManagementVenture Partner2023 β 2024San Francisco Bay Area
- Zenas BioPharmaBoard Membercurrent2024 β presentWaltham, Massachusetts, United States
- Regulus TherapeuticsBoard Membercurrent2019 β presentSan Diego, California
- Addex TherapeuticsBoard Membercurrent2018 β presentGeneva, Switzerland
- Humanetics CorporationBoard Membercurrent2022 β presentMinneapolis, Minnesota, United States
- Trevena, Inc.Board Member2013 β 2024Chesterbrook, Pennsylvania
- Hexima Limited (ASX:HXL)Board Member2021 β 2023Melbourne, Victoria, Australia
- New Enterprise Associates (NEA)Venture Advisor2019 β 2022
- New Enterprise Associates (NEA)Partner2006 β 2018
- Oventus Medical LtdBoard Member2020 β 2022Brisbane, Queensland, Australia
- Qool TherapeuticsBoard Member2019 β 2021Mountain View, CA
- Dermira, Inc.Board Member2011 β 2020Menlo Park, California
- TriVascular, IncBoard Member2008 β 2016Santa Rosa, California
- Hyperion TherapeuticsBoard Member2009 β 2015South San Francisco, California
- Transcept Pharmaceuticals, Inc.Board Member2009 β 2014Richmond, California
- MPM CapitalPartner2001 β 2006
- Franklin Templeton InvestmentsPortfolio Manager1998 β 2000
- Alex. Brown & SonsAnalyst1994 β 1996San Francisco, California
- GEFinancial Analyst1992 β 1994San Jose, California
Education
- Stanford University Graduate School of BusinessMaster of Business Administration (MBA)
- Dartmouth CollegeBachelor of Arts (B.A.), Economics
- Executive Education / Stanford Graduate School of BusinessDirectors' Consortium
Skills & more
- Chartered Financial Analyst (CFA) β CFA Institute
From Jake's professional profile.
Same school
Also attended Stanford University Graduate School of Business1,147
+ 1,141 more
Also attended Dartmouth College310
+ 304 more
Shared employers
Also worked at SR One Capital Management30
+ 24 more
Also worked at New Enterprise Associates (NEA)113
+ 107 more
Also worked at Dermira, Inc.2
Also worked at Franklin Templeton Investments30
+ 24 more
Deals Β· 5
Zenas BioPharma, Inc.Board seat
via SR One Capital Management Β· filed May 2024 Β· $200.1M raise
Addex Therapeutics Ltd.Board seat
via SR One Capital Management Β· filed Apr 2023 Β· $3.7M raise
Regulus Therapeutics Inc.Board seat
via SR One Capital Management Β· filed Dec 2021 Β· $34.6M raise
DermiraBoard seat
via SR One Capital Management Β· filed Dec 2018 Β· $1M raise
TrivascularBoard seat
via SR One Capital Management Β· filed Aug 2015 Β· $10M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at SR One Capital Management
Network3
Investors connected to Jake in public investor directories β a warm-intro map.



































